Global contract development and manufacturing organisation (CDMO) Vetter has been awarded Frost & Sullivan’s 2023 Global Customer Value Leadership Award in the aseptic fill-and-finish market.
The award, presented annually by the international growth strategy consulting firm, focuses on business and customer impact, industry status and trends in the market.
In previous years, the CDMO was awarded for their Customer Value Leadership and their Customer Service Leadership.
Frost & Sullivan applies an analytical process to evaluate nominees for each award category. The process involves a detailed evaluation of best practices criteria across the two dimensions – business and customer – for each nominated company.
Vetter’s core service offerings include drug product development, clinical and commercial aseptic filling, device assembly and secondary packaging.
Frost & Sullivan’s senior industry analyst Surbhi Gupta said, “Vetter offers highly specialised, state-of-the-art parenteral development and manufacturing expertise for the entire life cycle, from clinical development to commercial production and packaging.
“Through unwavering dedication to delivering the highest quality products and services and their exceptional knowledge and expertise, they strive to ensure their customers receive the best possible services.”
Frost & Sullivan’s best practices research analyst Pavel Zhebrouski said, “In 2021, we recognised Vetter for its business and customer impact, and we remain impressed with the continuous innovation and sustained leadership. Vetter uniquely leverages its expertise to meet its customers’ needs, particularly the growing transition to injectables.”
Vetter managing director Peter Soelkner added, “We always make our best efforts to provide customers with qualities that are highlighted in this prestigious award. We leverage our seven decades of experience and over 6,000 employees to do so.”
